Invagen Pharmaceuticals, Inc.

Number of records: 1

SEC Filing	Company/Stock	Trade Date	Transaction	Shares	Avg. Price	Total	% Holdings	Gain/Loss
13-Oct-22 8:52 PM View:	Avenue Therapeutics, Inc. (ATXI)	11-Oct-22	Private Sale	388,888	$7.71	$2,999,880.00	(100%) 388.89K to 0